It'll pay to think like a contrarian in 2020, and this 6.4%-yielding dividend payer is proof...‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

SPONSORED Stock Legend Says to Buy These Three Ultra-Cheap Stocks Now Stocks are suddenly available at their cheapest prices in years. Some are trading for 40%... 60%... even 75% off. But he says three in particular are must-buys. Find out the details that will make your retirement here. MARKET TRENDS My Favorite Stock Right Now - With a 6.4% Yield! Marc Lichtenfeld, Chief Income Strategist, The Oxford Club I am often asked what my favorite stock is... It's a tough question to answer because there are a lot of variables to consider, including how much risk an investor can handle. But when I look at the market, one stock has emerged as my absolute favorite right now, and it will probably surprise you. Wall Street absolutely hates the stock. Of the 27 analysts on the Street who cover it, only four rate it a "Buy." That's actually a positive sign... SPONSORED You Could Get RICH by January 21, 2022... Yes, on This Exact Day America's No. 1 expert reveals the opportunity of a lifetime. A small grubstake today... could help secure your future. Even in this post-coronavirus market. Click Here One thing you should know about me is that I don't care what Wall Street thinks. Early in my career, I was trained by one of Wall Street's most contrarian (not to mention smartest and most successful) research directors. He taught me to question everything. I learned that when Wall Street leans heavily in one direction, I should be seriously thinking about going the opposite way. That's how I've been able to score the biggest wins in my career, like a 2,381% gain in AbbVie (NYSE: ABBV) a few years ago when everyone on Wall Street believed the drug company was a has-been because its biggest-selling drug might've faced generic competition. I more than quadrupled readers' money in Texas Instruments (Nasdaq: TXN) when I recommended the stock despite semiconductor stocks having been stuck in neutral for nine years. They started shooting higher almost immediately after. And I tripled subscribers' money in Raytheon (NYSE: RTX) at a time when no one wanted to touch defense contractors due to the federal budget sequestration. My current favorite stock has a 6.4% yield and is the most attractive stock in its beaten-up sector... Click here to visit Wealthy Retirement and read more. MORE FROM WEALTHY RETIREMENT The Market's Biggest Winner What CEOs Don't Get About Share Buybacks Can a 14% Yield Be Safe? Facebook Twitter Email Share SPONSORED URGENT: Major Data on COVID-19 Expected Any Moment... (Could Send This Drugmaker's Stock Soaring)... "We're prepared as a company to make sure we get this medicine to as many patients as possible," the company's CEO reported... And the world's leading virus expert, Dr. Anthony Fauci, said, "I'm very optimistic [about the drug's potential]." This could be a godsend for humanity... gigantic for the drugmaker... and life-changing for investors who get in TODAY. To see how to get the ticker symbol, click HERE . You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2020 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.